HotSpot Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
HotSpot Therapeutics, Inc. - overview
Established
2017
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in Massachusetts, US, HotSpot Therapeutics, Inc. provides a platform Smart Allostery for the research and development of allosteric therapeutics. In November 2021, the firm raised USD 100 million in Series C funding led by investor Pivotal Life Sciences, with participation from investors B Capital Group, CaaS Capital Management, Life Sciences Partners, Monashee Investment Management, Pavilion Capital Partners, and Revelation Partners. Returning investors Atlas Venture, MRL Ventures Fund, Sofinnova Partners, SR One, and Tekla Capital Management also participated in the round.
Current Investors
Atlas Venture, Sofinnova Partners, SR One
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.hotspotthera.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.